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Summary 
In this report we outline the results of a study funded by the Scottish 
Government and the University of Glasgow to provide estimates of the 
prevalence of problem drug misuse in Scotland. The estimates refer to 
the calendar year 2006. The study used the capture-recapture method 
and focussed on those aged 15-64 years old. Estimates of the 
prevalence of opiate and / or benzodiazepine misuse have been 
provided for every Council area, Drug and Alcohol Action Team (ADAT) 
area, NHS Board area, Community Justice Authority area and Police 
Force area within Scotland. Estimates of the prevalence of drug 
injecting are also given at the Council and NHS Board area level. 
These estimates are compared with the results of a previous study 
relating to 2003.  
In addition, this study has also provided estimates of the prevalence of 
opiate and / or benzodiazepine misuse at the Community Health 
Partnership (CHP) level within Fife and Glasgow. There were too few 
data to provide estimates for crack cocaine use. Moreover, there was 
difficulty obtaining estimates of psychostimulant use more generally. 
In terms of the national prevalence of problem drug misuse we 
estimate that there were 55,328 individuals misusing opiates and / or 
benzodiazepines in the year 2006. This corresponds to 1.62% of the 
population aged between 15 and 64. The 95% confidence interval (CI) 
attached to the national estimate ranges from 54,451 to 57,234 (1.59-
1.67%).  The proportion estimated to be female is 30% and male 70%.   
The age breakdown among males was 24% aged between 15 and 24, 
48% between 25 and 34 and 28% aged between 35-64. 
In terms of the local estimates we have identified problem drug misuse 
in every Council area in Scotland. Aside from the comparatively low 
prevalence rates found in island Council areas, the prevalence of 
problem drug misuse by Council area has ranged from 0.53% (95% CI 
0.44-0.64%) in Moray and 0.66% (95% CI 0.53-0.85%) in the Scottish 
Borders through to 3.27% (95% CI 3.15-3.44%) in Glasgow City. The 
highest prevalence of problem drug misuse within a ADAT area is to be 
found in the Dundee City ADAT area, with a prevalence rate of 2.60% 
of those aged 15 to 64 (95% CI 2.33-3.11%), followed by Greater 
Glasgow with a prevalence of 2.53% of the 15 to 64 age range (95% CI 
2.46-2.66%). With that prevalence rate, Greater Glasgow is also the 
NHS Board with the highest prevalence. Finally, the highest prevalence 
rates in terms of Police Force areas were found in the Strathclyde 
Police Force area. This is not entirely unexpected as over half of the 
known problem drug users in Scotland reside in that area. 
In terms of drug injecting we estimate that 23,933 people were injecting 
opiates and/or benzodiazepines in 2006 (95% CI 21,655-27,143).  The 
  
highest drug injecting prevalence rates were identified in the Greater 
Glasgow and Clyde NHS Board areas; in that area it is estimated that 
just over 1% of the population inject drugs. 
Overall the prevalence of problem drug use increased in Scotland from 
51,582 (95% CI 1.84%-2.01%) to 55,328 in 2006. When comparing like 
for like prevalence for the 15 to 54 age group, the confidence interval 
for the 2003 estimate was (95% CI 1.84%-2.01%). The approximate 
adjusted confidence interval for the 2006 estimate is (95% CI 1.95%-
2.05%). The confidence intervals have quite a large degree of overlap 
but changes in methodology between 2003 and 2006 preclude a formal 
test of significance. 
There was however an increase in injecting prevalence nationally. For 
mainland Scotland, the prevalence increased from 18,737 in 2003 to 
23,933 in 2006. The increase in like for like rates (age 15 to 54) is from 
0.67% (95% CI 0.63-0.72%) to 0.86% (95% CI 0.77-0.97%). There 
have, however, been some methodological changes and issues with 
the data quality that would suggest it may not be appropriate to regard 
this as true increase in the prevalence of drug injecting in Scotland 
between 2003 and 2006. 
There have been some data quality issues that have caused 
methodological problems for the study, however this study 
demonstrates that it is possible to undertake a repeated comparable 
analysis to provide successive prevalence estimates over time. 
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1 Introduction 
In this report we outline the results of research funded by the Scottish 
Government and the University of Glasgow, commissioned by the 
Information and Statistics Division of the NHS in Scotland. The 
research was carried out jointly by the Centre for Drug Misuse 
Research at the University of Glasgow and Health Protection Scotland 
to provide national and local estimates of the prevalence of problem 
drug misuse within Scotland for the year 2006. Previously estimates of 
the prevalence of problem drug use and drug injecting were obtained 
for 2000 and 2003 (Hay et al, 2005). This study sought to replicate 
those analyses to provide comparable estimates. This study also 
attempts to provide information on the extent of psychostimulant use in 
Scotland. Change in the extent of drug use in Scotland is examined by 
comparing the prevalence estimates for 2006 with the prevalence 
estimates from 2003. 
Providing comparable estimates of the prevalence of problem drug use 
at both the national and local level across Scotland is far from a 
straightforward exercise. Although the methods used to estimate 
prevalence within this study are becoming more established with their 
increasing use in different settings, this study appears to be one of the 
few that sets out to obtain prevalence estimates that can be directly 
compared with a previous study. Thus the study has to combine 
comparability and consistency across the different geographical areas 
and across time. 
This Executive Report outlines the main results of the study, in 
particular the prevalence estimates at the Council, ADAT, NHS Board, 
Community Justice Authority area and Police Force area levels for both 
problem drug misuse and drug injecting. The Community Health 
Partnership (CHP) area results have also been derived and can be 
made available.  
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2 Aims and Objectives 
The aims of the study were to: 
• Estimate the national prevalence of problem drug use in 2006 
• Estimate the prevalence of problem drug use at the CHP area 
level in 2006 
• Estimate the prevalence of problem drug use at the Council area 
level in 2006 
• Estimate the prevalence of problem drug use at the ADAT area 
level in 2006 
• Estimate the prevalence of problem drug use at the NHS Board 
area level in 2006 
• Estimate the prevalence of problem drug use at the Police Force 
area level in 2006 
• Estimate the prevalence of problem drug use at the Community 
Justice area level in 2006 
• Estimate the prevalence of drug injecting at the Council area 
level in 2006 
• Estimate the prevalence of drug injecting at the NHS Board area 
level in 2006 
• Provide information on the extent of psychostimulant use  
• Compare the prevalence estimates with the results of the 2000 
and 2003 studies. 
The objectives of the study were therefore to: 
• Derive and state a definition of problem drug use 
• Stratify the available data on drug use in Scotland by CHP, 
Council, ADAT, NHS Board, Community Justice area and Police 
Force area levels using postcode district data 
• Use the capture-recapture method to provide comparable 
prevalence estimates to those provided in the 2000 and 2003 
studies 
• Adapt the capture-recapture method to provide problem drug 
use prevalence estimates at the CHP level that are consistent 
with Council area estimates 
• Use the capture-recapture method to provide drug injecting 
prevalence estimates at the Council area level that are 
consistent with NHS Board estimates 
• Use the capture-recapture method to provide estimates of the 
prevalence of psychostimulant use at the Council area level. 
 
Due to lack of data on crack cocaine use, and uncertainty surrounding 
the applicability of using capture-recapture methods to estimate the 
prevalence of other forms of psychostimulant use, the last objective 
has not been successfully met. 
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3 Methods 
In this section we provide a brief description of the more pertinent 
aspects of the methods used to generate estimates of the prevalence 
of drug misuse in Scotland. The capture-recapture method has been 
described in previous reports and in the scientific literature particularly 
in the context of providing a national or regional estimate by combining 
stratified estimates (Gemmell, Millar and Hay, 2004; Hickman et al, 
2004). 
The capture-recapture method fits statistical models to describe the 
pattern of overlap between different sources of data on the identifiable 
drug misusing population and then applies this knowledge to assess 
the likely size of the hidden problem drug misusing population. The 
estimate of the total drug misusing population is arrived at by 
combining the minimum enumeration of identifiable drug misusers and 
the statistically estimated hidden population. Within this study, it was 
necessary to undertake separate analyses of the available data for 
each Council area. It was also necessary to analyse the overlaps 
between these data sources in order to produce a series of estimates 
of the hidden drug misusing population. The process of arriving at a 
national estimate involved summing all of those local estimates. The 
main unit of analysis in this research has therefore been the Council 
area. On the basis of these Council area estimates, it has been 
possible to produce estimates for the differently configured NHS Board 
areas, ADAT areas and Police Force areas in Scotland. In addition, a 
separate analysis was undertaken for the South Lanarkshire Council 
area as it straddles the Greater Glasgow and Clyde NHS Board 
boundary.  
CHP, Council and NHS Board area of residence were assigned 
according to an individual’s postcode district of residence. As a 
consequence of this, the Council and NHS Board areas referred to in 
this study, and in particular the baseline populations aged 15 to 64, 
may differ from the actual Council or NHS Board areas. We can take 
the AB23 postcode district, which straddles Aberdeen City and 
Aberdeenshire, as an example. Information from the Postal Address 
File suggests that 60% of addresses in AB23 postcode district are in 
the City of Aberdeen therefore the whole of that postcode district has 
been assigned to the City of Aberdeen thus artificially inflating the 
population of the city and deflating the population of the neighbouring 
Aberdeenshire.  
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An appendix to this report details the Council and NHS Board 
population sizes used in this study, and their composition in terms of 
postcode districts. It was not possible to differentiate between the small 
parts of North Lanarkshire Council covered by Greater Glasgow, as 
that area is comprised of postcode districts that are mainly in Glasgow 
City.   
For most of the Council areas, the estimates were derived using four 
separate sources of data (treatment, hospital discharges, police and 
social work). In the Eilean Siar and Orkney Isles Council areas, there 
were insufficient data to perform capture-recapture analyses. Therefore 
the prevalence estimates in those areas were obtained by applying the 
known (from the Scottish Drug Misuse Database data) to unknown ratio 
of problem drug users found elsewhere in the Northern Constabulary 
area to both of those Council areas.  
Data have been collected only on problem drug users aged between 15 
and 64. The previous Scottish studies employed the age range 15 to 
54, however this study altered the range to make it consistent with 
other UK studies and to meet European Monitoring Centre for Drugs 
and Drug Addiction reporting standards. It is extremely unlikely that the 
increase in age range has had significant impact on the estimated 
number of opiate and / or benzodiazepines users. The prevalence 
estimates contained in this report relate to the calendar year 2006.  
The population figures used in the report are the 2006 mid-year 
estimates (© Crown copyright, data supplied by General Register 
Office for Scotland). Population figures for age group / gender strata 
have also been obtained from the published mid year estimates.  
Confidence Intervals 
Confidence intervals were derived for each stratified estimate using the 
approach proposed by Cormack (1992). The confidence intervals for 
estimates obtained by combining stratified estimates (e.g. all mainland 
Council and NHS Board estimates, along with the national estimate) 
were derived following the approach outlined in Millar, Gemmell and 
Hay (2004) where the distribution of each confidence interval is 
approximated by a log-normal distribution and 5,000 samples from 
those distributions are summed to provide confidence intervals for the 
totals. The confidence intervals are recalculated at each geographical 
level, i.e. the confidence interval for Lothian and Borders Police Force 
areas was derived in the manner described above by summing the 
distributions for the Lothian NHS Board and the Borders NHS Board 
areas. This will, however, have the effect of skewing the resultant 
confidence interval reflecting the fact that the individual estimates are 
not symmetric and often have higher upper limits.  
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Confidence intervals have not been derived for the Orkney Isles 
Council area. This has a minimal impact on the Northern Constabulary 
estimate due to the relatively small number of drug users found in this 
area.   
Drug Injecting 
Four data sources were used in the capture-recapture analyses to 
estimate the prevalence of drug injecting at NHS Board area level. 
Those sources were treatment data collated from ISD, Social Enquiry 
Reports, drug-related acute hospital discharges and hepatitis C virus 
tests. Further details on the definitions used for identifying injecting 
drug users are provided in Chapter 4. Although data on injecting were 
collected from a number of treatment services across Scotland, it was 
not possible to use such data in a beneficial manner in the analyses. 
Although both the treatment source and Social Enquiry Reports record 
the current injecting status of patients / clients, there is the potential for 
both the hepatitis C data source and the hospital discharges source to 
include non-injectors. In the case of the hepatitis C virus data, the tests 
carried out in 2006 could include people who had injected drugs in the 
past and either now do not inject drugs or indeed use drugs. In the 
case of the hospital discharges source each individual within that 
source has received a diagnosis of mental and behavioural disorders 
either due to use of opioid or multiple psychoactive drugs (ICD10 
Codes F11 and F19) and a diagnosis of one of four conditions 
indicative of drug injecting such as endocarditis or abscesses (see 
section 4.2 for full list of conditions). It is however possible that this 
data source could include opiate users who have those conditions but 
do not inject. 
For the Council area injecting estimates we constructed four samples: 
the ISD treatment data for 2006/07, Social Enquiry Reports, hospital 
discharges and ISD treatment data for 2005/06. Despite using two 
separate years of ISD treatment data, we still contend that the 
estimates will refer to the calendar year 2006 as it is likely that the vast 
majority of those identified as drug injectors in the period 1st April 2005 
to 31st December 2005 or the period 1st January 2007 to 31st March 
2007 would have been injecting drugs at some point in the calendar 
year 2006  As with previous studies, these Council area estimates were 
adjusted to ensure that the area-stratified estimates summed to give 
the relevant NHS Board area level estimate. Thus each stratified 
estimate was rescaled by a factor corresponding to the ratio of the 
summed estimates to the NHS Board area estimate. The reasons for 
this are twofold, first to ensure consistency between the different area 
estimates and second to aid comparability across NHS Board areas in 
relation to the number of Council areas they cover.  
 6
In the Borders NHS Board area, there were too few data that could be 
used within a capture-recapture analysis; in particular there were very 
few hospital discharges data and only three individuals identified 
through the Social Enquiry Report source. The previous study in 2003 
had used a mortality multiplier method to estimate the prevalence of 
injecting in that NHS Board area. The mortality rate in that analysis was 
derived from a study carried out in 2001. It was not thought to be 
appropriate to use such an out of date mortality rate to obtain the 2006 
estimate. To derive an estimate for the Borders we simply applied the 
proportion of problem drug users estimated to be injectors in the rest of 
mainland Scotland to derive an approximate injecting estimate for the 
Borders. 
The available data sources identified very few drug injectors in the 
Orkney Isles or the Western Isles NHS Board areas. It was therefore 
not possible to provide estimates of the prevalence of drug injecting in 
those two areas. Aside from the treatment data, there were very few 
individuals identified as drug injectors in Shetland. Thus again there 
were insufficient data to obtain an injecting prevalence estimate using 
the capture-recapture method.  
 CHP Estimates 
Only 3 Council areas have CHP areas within them. These are Fife, 
Glasgow City and Highland. All other CHP areas are coterminous with 
Council area. Each CHP area in Fife, Glasgow or Highland was 
constructed as one or more postcode districts and each postcode 
district in Scotland was assigned to a CHP area on the basis of where 
most of the residents live. CHP area estimates were obtained for 
Glasgow and Fife, but due to there being extremely small numbers of 
people identified as resident in the North Highland CHP it was not 
possible to provide CHP level estimates for that Council area. The CHP 
estimates within the Glasgow Council area have been rescaled in a 
similar fashion to that described above for Council level injecting 
estimates to ensure that that combined local estimates added up to the 
relevant Glasgow area total estimate. There did appear to be a specific 
problem with the Glasgow data as many individuals appeared to be 
turning up in more than one CHP area. That caused issues with 
deriving CHP level estimates for Glasgow as the CHP estimates 
appear very large compared to the total estimate for Glasgow, even 
though they look acceptable from a statistical point of view. This 
problem was not present in the Fife data where the summed CHP 
estimates appeared to be similar to the estimates derived for Fife as a 
whole. We therefore took the best estimate for the Fife NHS Board / 
Fife Council area to be the sum of the three CHP area estimates within 
Fife as, although other estimates at the NHS Board level were similar, 
in the CHP level analyses the models provided a better fit to the data.  
Comparisons between 2003 and 2006 
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Although the capture-recapture method was used in the both the 2000 
and the 2003 studies, there were some differences in how the method 
was applied. Some of those differences have been described above 
and in the reports from previous studies, such as the use of postcode 
district data instead of postcode sector data and the use of hospital 
admissions data in 2003 and 2006. In general the quality of the data 
collated in 2006 was not as good as that available in 2000 or 2003. 
This did cause problems in fitting models to the available data in some 
areas and steps were taken (described below) to remedy this.  
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4 Data  
In this section we provide a more detailed description of the data 
sources employed in this study. In general the approach taken was to 
collect all available data on the use of illicit substances across all data 
sources in 2006. The illicit use of any opiate or benzodiazepine, or 
additionally the prescribed use of methadone, is described within the 
study as opiate and / or benzodiazepine use. Where a data source 
notes that an individual has injected any illicit drug at any point within 
2006 then that person is noted as a drug injector and those data on 
drug injectors are used to provide an estimate of drug injecting. As 
will be seen below, none of the contributing data sources provided 
information on the severity of an individual’s drug use or their level of 
addiction. For the purposes of the study we define problem drug use 
as opiate and / or benzodiazepine use (thus assuming that all illicit use 
of those drugs or the use of methadone is considered problematic). 
However, the nature of the contributing data sources suggests that this 
assumption cannot be made for psychostimulants within this study.  
4.1 Scottish Drug Misuse Database 
The most substantial data source we have drawn upon in this research 
is the Scottish Drug Misuse Database. This database obtains 
anonymised demographic data on individuals at the point of first 
contact with a range of drug services, including non-statutory agencies 
and general practitioners. The data on drug users held on the Scottish 
Drug Misuse Database was augmented by data held by specialist 
agencies on the total numbers in treatment. Although this was not 
always of assistance when deriving estimates as including data 
collected directly from some treatment agencies affected the statistical 
analyses and the resultant estimates, to the extent that the quality of 
the data could be questionable.    
The data from all treatment agencies that contributed to the study were 
combined with the agency returns to the Scottish Drug Misuse 
Database to obtain a single data source at the Council area level. This 
dataset was then reviewed to remove erroneous or incomplete data 
records, those which did not meet the case definition of the study, and 
to eliminate multiple occurrences of a unique individual. As the Scottish 
Drug Misuse Database provided the most comprehensive and 
consistent source of information on drug users in contact with services 
across Scotland, any additional data found within the Scottish Drug 
Misuse Database relating to an individual was included within the 
analyses, such as the injecting status.   
Although many needle exchanges collate sufficient information on their 
clients to enable their inclusion within a capture-recapture analysis, the 
provision of needle exchanges across Scotland is inconsistent; 
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therefore needle exchange data have not been used within these 
analyses. The data from needle exchanges that contribute to the 
Scottish Drug Misuse Database have not been included in the Scottish 
Drug Misuse Database source. 
It was not possible to augment the ISD treatment data with locally 
collected data in Aberdeen City, Highland or Stirling. When this was 
attempted, it was not possible to fit appropriate models to the overlap 
pattern. This could be indicative of data quality issues, however it was 
not possible within the scope of this study to examine that issue in 
great detail. However, when comparing estimates for the rest of 
Scotland, sensitivity analyses suggest that restricting the treatment 
data to those collected directly from ISD does not unduly impact on the 
prevalence estimates.  
4.2 Hospital Discharges 
The Information Services Division (ISD) of National Services Scotland 
collates information on all hospital discharges in Scotland. The data 
were derived from inpatient and day case discharge summaries from 
non-obstetric, non-psychiatric specialties in general acute NHS 
hospitals in Scotland. The data did not distinguish whether the 
individual died in hospital or not, however people who did die in 
hospital in the relevant time period were still classed as drug injectors. 
The system records diseases using the World Health Organization's 
International Classification of Diseases 10th Revision (ICD10) and up 
to six diagnoses can be given.  An individual was included in this 
hospital admission source if they had a diagnosis that related to their 
opioid use (ICD10 F11) or their use of multiple psychoactive drugs 
(ICD10 F19). Opioid use did not have to be the individual’s primary 
diagnosis, it could be any of the six diagnoses listed, therefore this 
source includes discharges where the primary diagnosis was for 
another condition such as abscesses or for injuries or for conditions not 
directly related to drug misuse such as diabetes. Where there was a 
diagnosis of a condition related to drug injecting (acute and subacute 
infective endocarditis, phlebitis / thrombophlebitis, cutaneous abscess, 
furuncle and carbuncle or cellulitis; ICD10 I35, I80 and L02) then it was 
also assumed that the individual was a drug injector. This is the same 
approach to constructing an injecting data source from hospital data as 
taken in the 2003 study. 
4.3 Social Enquiry Reports 
Social Enquiry Reports are compiled by Social Work or corresponding 
departments to help in assessing the most suitable form of sentencing 
where an individual is being dealt with by the criminal justice system. 
As the report is written in relation to the individual's offending behaviour 
and a particular crime, any drugs that an individual is using may not be 
noted if the Social Worker does not feel that this is related to the case. 
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This data source is, however, particularly relevant in identifying drug 
users who have committed acquisitive crime and who may be less 
likely to be contacting drug treatment agencies. All 32 Councils granted 
the research project access to Social Enquiry Reports and all available 
reports pertaining to 2005/06 and 2006/07 were screened by trained 
data collectors. Those reports relevant to calendar year 2006 were 
used in the analyses. It is not possible to summarise the actual 
numbers of reports screened, however in 2005/06 there were 42,023 
reports submitted to Scottish Courts, pertaining to 27,466 individuals. 
The figures for 2006/07 were 41,359 reports on 28,349 individuals 
(Scottish Government, 2008). Thus for each Council area, a Social 
Enquiry Report data source was compiled which contained information 
on those who had the use of opiates or benzodiazepines noted within a 
report. The injecting status, as far as could be ascertained, was also 
noted. Data on cocaine use were also collated.  
4.4 Police 
Data on individuals who had been detained under the Misuse of Drugs 
Act were made available by all of Scotland's Police Forces. Data 
pertaining to individuals detained for opiate or benzodiazepine offences 
were collated within a Police source for each Council area. Data on 
cocaine use were also requested, however for most areas there were 
difficulties in differentiating between powder cocaine and crack cocaine 
offences. As the Police data only relates to the possession of a drug, 
no information was available on the individuals’ injecting status. 
4.5 Health Protection Scotland (Hepatitis C Virus) 
Health Protection Scotland collates information on those receiving a 
test for infection with the hepatitis C virus. As drug injecting or needle 
sharing could be noted as a risk factor a list of drug injectors could be 
constructed.  
4.6 Summary  
The data from each of the above data sources were encrypted and 
cleaned to remove multiple counting within source. Where a drug user 
appeared in more than one CHP or Council area within an NHS Board 
area the record with the latest date was used to indicate the area of 
residence. To compare across data sources a ‘hard matching’ 
approach was taken, where two (or more) records were classed as a 
match if the forename initial, surname initial, gender and date of birth 
were the same (as opposed to the ‘soft matching’ that would allow 
different forename initials). It should be noted that the previous 2003 
study used soft matching. The decision to change to hard matching 
was based on work completed during a Home Office funded study in 
England, where soft matching and hard matching were compared. The 
sensitivity analyses that examined this issue were not published, 
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however it was shown, using data from England, that switching from 
soft matching to hard matching would probably increase the estimate. 
The Home Office Study did, however conclude that hard matching was 
more appropriate. A hard matching approach was therefore taken in 
this study.  Table 1 summarises the data on known opiate / 
benzodiazepine misuse from the various sources by Council area. For 
reasons of confidentiality Table 1 does not include the three island 
Council areas. The treatment data column also provides (in brackets) 
the total amount of the data obtained from ISD as an extract from the 
Scottish Drug Misuse Database. Table 2 presents data on drug 
injecting by NHS Board area, again excluding the three island NHS 
Board areas. The only treatment data used within the injecting 
analyses came directly from the Scottish Drug Misuse Database. 
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Table 1 Summary of data on known problem drug users by 
Council area (aged 15 to 64) 
 
Council Area 
Treatment 
(SDMD only) 
Hospital 
Admissions
Social Enquiry 
Reports Police Total1 
Aberdeen City  586 (362) 314 494 331 1,381
Aberdeenshire 650 (290) 73 72 154 778
Angus 318 (127) 17 129 46 430
Argyll & Bute 104 (81) 16 43 106 220
Clackmannanshire 118 (101) 16 76 36 206
Dumfries & Galloway 512 (250) 65 159 115 684
Dundee City 1,107 (510) 59 450 179 1,411
East Ayrshire 749 (368) 136 114 289 1,022
East Dunbartonshire 85 (64) 12 37 44 157
East Lothian 369 (232) 37 37 38 433
East Renfrewshire  65 (50) 23 43 96 196
Edinburgh, City of 2,343 (1,115) 330 372 362 2,868
Falkirk 329 (234) 35 141 86 480
Fife 1,365 (1,045) 216 437 187 1,776
Glasgow City 6,755 (1,476) 476 872 1,881 8,283
Highland 648 (260) 40 128 126 803
Inverclyde 296 (291) 56 137 247 589
Midlothian 382 (137) 40 54 39 433
Moray 122 (80) 19 40 47 178
North Ayrshire 800 (353) 163 98 330 1,086
North Lanarkshire 667 (238) 94 221 452 1,217
Perth & Kinross 298 (121) 53 122 78 443
Renfrewshire 428 (323) 96 225 402 934
Scottish Borders 182 (94) 22 57 22 235
South Ayrshire 417 (184) 86 105 171 604
South Lanarkshire 1,076 (332) 70 244 428 1,751
Stirling 262 (124) 31 108 75 402
West Dunbartonshire 562 (336) 33 132 255 804
West Lothian 569 (406) 62 149 59 677
MAINLAND SCOTLAND 22,474 (9,584) 2,690 5,296 6,681 30,481
 
1 As an individual can be present in more than one source, the columns cannot 
be added to provide the total (which accounts for multiple occurrences). 
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Table 2 Summary of data on known drug injectors by NHS 
Board area (age 15 to 64) 
 
NHS Board Area Treatment 
Hospital 
Admissions
Social Enquiry 
Reports Hepatitis C Total1 
Ayrshire & Arran 287 154 67 34 489
Borders 15 * * * 23
Dumfries & Galloway 133 28 34 44 209
Fife 492 59 107 24 609
Forth Valley 287 35 77 33 374
Grampian 431 166 69 105 713
Greater Glasgow and Clyde 638 329 245 383 1,498
Highland 119 * * 24 168
Lanarkshire 200 41 58 33 314
Lothian 540 96 72 121 766
Tayside 335 34 142 * 470
MAINLAND SCOTLAND 3,477 953 900 812 5,633
1 As an individual can be present in more than one source, the columns cannot be 
added to provide the total (which accounts for multiple occurrences).  
2 Data suppressed to prevent disclosure of small numbers. 
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5 Results 
In this section we present the information on both the national and local 
estimated prevalence of problem drug misuse within Scotland. We 
provide a national estimate first, followed by separate estimates for 
each Council, ADAT, NHS Board, Community Justice Authority area 
and Police Force area. At each point where we present the local 
prevalence information, we provide a graphical representation of the 
data on a map of Scotland, followed by a bar chart and a table 
summarising the prevalence estimates and associated 95% confidence 
intervals. We also derived estimates of the prevalence of opiate and / 
or benzodiazepine use at the CHP level, and these are available on 
request.  We then provide estimates of the prevalence of drug injecting 
at the NHS Board and Council area levels. It was not possible to 
provide meaningful information on psychostimulant use. 
5.1 Opiates and Benzodiazepine Use 
5.1.1 National Prevalence 
To obtain a national estimate of the prevalence of problem drug misuse 
in the year 2006, we have summed the local estimates for each of the 
32 Council areas in Scotland. On this basis, we estimate that there are 
55,328 individuals who are misusing opiates or benzodiazepines within 
Scotland. The 95% confidence interval attached to this estimate is 
54,451 to 57,234. This corresponds to a prevalence rate of 1.62% of 
the Scottish population aged between 15 and 64 (95% CI 1.59-1.67%).  
5.1.2 Council Areas 
Table 3 summarises the estimates of the prevalence of problem drug 
misuse for each of the 32 Council areas in Scotland. This information is 
presented as a map in Figure 1. In Figures 2 and 3 we have 
summarised the information on the prevalence of problem drug misuse 
by differentiating between the rural and non-rural Council areas. Within 
this research a Council area has been classified as rural if it has a 
population density of less than one person per hectare (Scottish 
Executive, 2000).  
As one might have expected, the highest prevalence rates amongst the 
non-rural Council areas are found in the major urban centres. The 
highest prevalence rate is Glasgow at 3.27% of the population aged 15 
to 64 (95% CI 3.15-3.44%). The next highest is West Dunbartonshire at 
2.61% (95% CI 2.33-2.96%). The third highest is Dundee City at 2.60% 
(95% CI 2.33-3.11%). It can also be clearly seen that whilst the 
prevalence of problem drug misuse is lower in the rural as opposed to 
the non-rural areas, problem drug misuse is occurring in both rural and 
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non-rural areas. Indeed, comparatively high levels of problem drug use 
are found in East Ayrshire. 
Table 3  Estimates of the number of problem drug users by 
Council area (age 15 to 64) 
 
Area Estimate Prevalence 
 n  95% CI %  95% CI 
Aberdeen City  2,597 2,339-2,896 1.80 1.62-2.01 
Aberdeenshire 1,257 1,139-1,400 0.80 0.73-0.89 
Angus 868 738-1,039 1.24 1.05-1.48 
Argyll & Bute 548 424-738 0.94 0.72-1.26 
Clackmannanshire 505 392-678 1.54 1.20-2.07 
Dumfries & Galloway 1,452 1,225-1,760 1.55 1.31-1.88 
Dundee City 2,454 2,204-2,935 2.60 2.33-3.11 
East Ayrshire 1,834 1,680-2,034 2.32 2.13-2.58 
East Dunbartonshire 457 330-673 0.67 0.48-0.98 
East Lothian 895 738-1,116 1.51 1.25-1.89 
East Renfrewshire  543 414-742 0.95 0.72-1.29 
Edinburgh, City of 5,315 4,933-5,778 1.61 1.50-1.75 
Eilean Siar1 63 30-204 0.38 0.18-1.21 
Falkirk 888 782-1,019 0.89 0.78-1.02 
Fife 3,015 2,817-3,271 1.27 1.18-1.37 
Glasgow City 13,256 12,762-13,931 3.27 3.15-3.44 
Highland 1,023 790-1,585 0.73 0.56-1.13 
Inverclyde 1,385 1,171-1,718 2.57 2.18-3.19 
Midlothian 648 574-744 1.24 1.10-1.43 
Moray 299 251-365 0.53 0.44-0.64 
North Ayrshire 1,808 1,656-2,033 2.04 1.87-2.30 
North Lanarkshire 3,247 2,908-3,690 1.49 1.34-1.70 
Orkney Isles1 19 0.15  
Perth & Kinross 873 737-1,099 0.97 0.82-1.22 
Renfrewshire 2,083 1,858-2,355 1.84 1.64-2.08 
Scottish Borders 466 376-600 0.66 0.53-0.85 
Shetland Isles 81 77-97 0.56 0.53-0.67 
South Ayrshire 1,055 948-1,184 1.47 1.32-1.65 
South Lanarkshire 3,014 2,714-3,376 1.47 1.32-1.65 
Stirling 756 602-970 1.30 1.04-1.67 
West Dunbartonshire 1,601 1,428-1,813 2.61 2.33-2.96 
West Lothian 1,023 933-1,132 0.91 0.83-1.00 
SCOTLAND 55,328 54,451-57,234 1.62 1.59-1.67 
1  Estimates for the Orkney Isles Council areas produced using the multiplier 
method (see Chapter 3) 
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Figure 1 Estimated prevalence of problem drug use by Council 
area (age 15 to 64) 
 
Note: Estimates for Orkney Isles Council area produced using the multiplier method 
(see Chapter 3) 
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Figure 2 Estimated prevalence of problem drug use by Council 
area (rural areas, age 15 to 64) 
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Note: Estimates for the Orkney Isles Council area produced using the multiplier 
method (see Chapter 3). This estimate does not have error bars attached to 
it, but is subject to error. 
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 Figure 3 Estimated prevalence of problem drug use by Council 
  area (non-rural areas, age 15 to 64)  
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5.1.3 ADAT Areas 
ADATs are the main local administrative entities for the co-ordinated 
response to drug misuse in Scotland. While some are mapped along 
NHS Board boundaries, other ADATs have divided in accordance with 
Council boundaries. In Figure 4 we present a graphical representation 
of drug misuse prevalence across the 22 ADATs. Figure 5 presents the 
prevalence estimates by ADAT area in the form of a bar chart whereas 
Table 4 summarises those data in a table. 
We see here that the Dundee City ADAT area has the highest 
prevalence rate at 2.60% (95% CI 2.33-3.11%), followed by the Greater 
Glasgow ADAT area at 2.53% (95% CI 2.46-2.66%). The Ayrshire & 
Arran ADAT area follows with a prevalence rate of 1.96% (95% CI 
1.86-2.10%). 
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Table 4 Estimates of the number of problem drug users by 
ADAT area (age 15 to 64) 
 
Area Total Estimate Prevalence 
 n  95% CI %  95% CI 
Aberdeen City  2,597 2,339-2,896 1.80 1.62-2.01 
Aberdeenshire 1,257 1,139-1,400 0.80 0.73-0.89 
Angus 868 738-1,039 1.24 1.05-1.48 
Argyll & Bute 548 424-738 0.94 0.72-1.26 
Ayrshire & Arran 4,697 4,454-5,029 1.96 1.86-2.10 
Borders 466 376-600 0.66 0.53-0.85 
Dumfries & Galloway 1,452 1,225-1,760 1.55 1.31-1.88 
Dundee City 2,454 2,204-2,935 2.60 2.33-3.11 
East Lothian 895 738-1,116 1.51 1.25-1.89 
Edinburgh City 5,315 4,933-5,778 1.61 1.50-1.75 
Fife 3,015 2,817-3,271 1.27 1.18-1.37 
Forth Valley 2,149 1,930-2,468 1.13 1.01-1.29 
Greater Glasgow & Clyde 20,502 19,881-21,487 2.53 2.46-2.66 
Highland 1,023 790-1,585 0.73 0.56-1.13 
Lanarkshire 5,084 4,543-5,725 1.36 1.22-1.53 
Midlothian 648 574-744 1.24 1.10-1.43 
Moray 299 251-365 0.53 0.44-0.64 
Orkney Isles1 19 0.15  
Perth & Kinross 873 737-1,099 0.97 0.82-1.22 
Shetland Isles 81 77-97 0.56 0.53-0.67 
West Lothian 1,023 933-1,132 0.91 0.83-1.0 
Western Isles 63 30-204 0.38 0.18-1.21 
SCOTLAND 55,328 54,451-57,234 1.62 1.59-1.67 
1 Estimates for the Orkney Isles ADAT area were produced using multiplier 
method (see Chapter 3).  
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Figure 4 Estimated prevalence of problem drug use by ADAT 
area (age 15 to 64) 
 
Note: Estimate for the Orkney Isles and ADAT areas produce using multiplier 
method (see Chapter 3).  
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Figure 5 Estimated prevalence of problem drug use by ADAT area 
(age 15 to 64) 
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Note: Estimates for the Orkney Isles ADAT area produced using the multiplier 
method (see Chapter 3). This estimate does not have error bars attached to 
it, but is subject to error. 
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5.1.4 NHS Board Areas 
 
In the next section we look at the same prevalence information, but this 
time divided in accordance with NHS Board areas. 
By expressing the estimated number of drug misusers in each area as 
a percentage of the population aged 15 to 64, it is possible to make 
comparisons across NHS Board areas. On that basis, the area with the 
highest prevalence rates for problem drug misuse is Greater Glasgow 
& Clyde at 2.53% (95% CI 2.46-2.66%). The next highest is Ayrshire & 
Arran at 1.96% (95% CI 1.86-2.10%). The third highest is Tayside at 
1.65% (95% CI 1.53-1.87%).  
The NHS Board area with the highest number of problem drug users is 
Greater Glasgow, where the estimated total is 20,502 (95% confidence 
interval 19,881 to 21,487). The next highest area is Lothian, where the 
estimated total is 7,881, (95% confidence interval 7,468-8,434).  
 
Table 5  Estimates of the number of problem drug users by 
NHS Board area (age 15 to 64) 
 
Area Total Estimate Prevalence 
 N  95% CI %  95% CI 
Ayrshire & Arran 4,697 4,454-5,029 1.96 1.86-2.10 
Borders 466 376-600 0.66 0.53-0.85 
Dumfries & Galloway 1,452 1,225-1,760 1.55 1.31-1.88 
Fife 3,015 2,817-3,271 1.27 1.18-1.37 
Forth Valley 2,149 1,930-2,468 1.13 1.01-1.29 
Grampian 4,153 3,867-4,498 1.16 1.08-1.26 
Greater Glasgow & Clyde 20,502 19,881-21,487 2.53 2.46-2.66 
Highland 1,571 1,300-2,166 0.79 0.65-1.09 
Lanarkshire 5,084 4,543-5,725 1.36 1.22-1.53 
Lothian  7,881 7,468-8,434 1.42 1.35-1.52 
Orkney Isles1 19 0.15  
Shetland Isles 81 77-99 0.56 0.53-0.69 
Tayside 4,195 3,885-4,747 1.65 1.53-1.87 
Western Isles 63 31-230 0.38 0.18-1.37 
SCOTLAND 55,328 54,451-57,234 1.62 1.59-1.67 
1 Estimates for Orkney Isles NHS Board areas were produced using multiplier 
method (see Chapter 3) 
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Figure 6 Estimated prevalence of problem drug use by NHS 
Board area (age 15 to 64) 
 
Note: Estimates for Orkney Isles NHS Board areas produced using multiplier 
method (see Chapter 3) 
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Figure 7 Estimated prevalence of problem drug use by NHS 
Board area (age 15 to 64) 
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Note: Estimates for Orkney Isles NHS Board areas produced using multiplier 
method (see Chapter 3). This estimate does not have error bars attached to 
it, but is subject to error. 
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5.1.5 Community Justice Authority Areas 
The following set of estimates relate to the Community Justice Authority 
(CJA) areas established in April 2006. The results for each of the eight 
areas are summarised in Table 6 and illustrated in Figures 8 and 9. 
The prevalence of problem drug use is highest in the Glasgow CJA 
area at 3.27% of the population aged 15-64 (95% CI 3.15–3.44%). The 
area with the second highest prevalence is the South West Scotland 
CJA with a prevalence rate of 1.85% (95% CI 1.75–1.98%) The area 
with the lowest prevalence is Northern with a rate of 0.98% (95% CI  
0.92–1.11%). 
Table 6  Estimates of the number of problem drug users by 
Community Justice Authority area (age 15 to 64) 
 
Area Total Estimate Prevalence 
 N  95% CI %  95% CI 
Fife & Forth Valley 5,164 4,870-5,569 1.20 1.14-1.30 
Glasgow 13,256 12,762-13,931 3.27 3.15-3.44 
Lanarkshire 6,261 5,808-6,859 1.48 1.38-1.62 
Lothian & Borders 8,347 7,930-8,921 1.34 1.27-1.43 
North Strathclyde 6,617 6,214-7,217 1.60 1.51-1.75 
Northern 5,339 4,964-6,039 0.98 0.92-1.11 
South West Scotland 6,149 5,821-6,608 1.85 1.75-1.98 
Tayside 4,195 3,885-4,747 1.65 1.53-1.87 
SCOTLAND 55,328 54,451-57,234 1.62 1.59-1.67 
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Figure 8 Estimated prevalence of problem drug use by 
Community Justice Authority area (age 15 to 64) 
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Figure 9 Estimated prevalence of problem drug use by 
Community Justice Authority area (age 15 to 64) 
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Note: Estimates for the Orkney Isles part of the Northern Community Justice Authority area 
are produced using multiplier method (see Chapter 3) 
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5.1.6 Police Force Areas 
Next we present the information on drug misuse prevalence by Police 
Force area. Again we present a table summarising the results then a 
map showing this information followed by a bar chart.  
Whilst drug misuse is clearly occurring in all Force areas, the 
prevalence of drug misuse is highest in the Strathclyde area at 2.08% 
of the population within the 15 to 64 age range (95% CI 2.03-2.17%). 
The area with the second highest prevalence is Tayside at 1.65% (95% 
CI 1.53-1.87%). The area with the lowest prevalence is the Northern 
Constabulary area at 0.64% (95% CI 0.51-0.97%). 
Table 7  Estimates of the number of problem drug users by 
Police Force area (age 15 to 64) 
 
Area Total Estimate Prevalence 
 N  95% CI %  95% CI 
Central 2,149 1,930-2,468 1.13 1.01-1.29 
Dumfries & Galloway 1,452 1,225-1,760 1.55 1.31-1.88 
Fife 3,015 2,817-3,271 1.27 1.18-1.37 
Grampian 4,153 3,867-4,498 1.16 1.08-1.26 
Lothian & Borders 8,347 7,930-8,921 1.34 1.27-1.43 
Northern1 1,186 948-1,784 0.64 0.51-0.97 
Strathclyde 30,831 30,077-32,049 2.08 2.03-2.17 
Tayside 4,195 3,885-4,747 1.65 1.53-1.87 
SCOTLAND 55,328 54,451-57,234 1.62 1.59-1.67 
Note: Estimates for Orkney Isles parts of the Northern Constabulary area are produced 
using multiplier method (see Chapter 3) 
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Figure 10 Estimated prevalence of problem drug use by Police 
Force area (age 15 to 64) 
 
Note: Estimates for Eilean Siar and Orkney Isles parts of the Northern Constabulary 
area are produced using multiplier method (see Chapter 3) 
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Figure 11 Estimated prevalence of problem drug use by Police 
Force area (age 15 to 64) 
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Note: Estimates for the Orkney Isles part of the Northern Constabulary area are 
produced using multiplier method (see Chapter 3) 
 31
5.1.7 Community Heath Partnership Areas 
Most Community Health Partnership (CHP) Areas are coterminous with 
the Council areas, and those results are provided in Section 5.1.2 
above. Only in three Council areas are there more than one CHP area, 
these are Fife, Glasgow City and Highland. There were insufficient data 
to carry out a capture-recapture analysis in at least one of the Highland 
CHP areas. We present in Table 8 the CHP estimates for Glasgow City 
and Fife.  
Table 8  Estimates of the number of problem drug users by 
Community Health Partnership area (age 15 to 64) in 
Glasgow City and Fife 
 
Area Total Estimate Prevalence 
 N  95% CI %  95% CI 
Dunfermline 988 866-1,140 1.06 0.93-1.23 
Glenrothes and North 
East Fife 689 585-831 0.83 0.70-1.00 
Kirkcaldy and 
Levenmouth 1,338 1,226-1,473 2.16 1.98-2.38 
  
East Glasgow 3,935 3,528-4,423 4.70 4.21-5.28 
North Glasgow 2,514 2,247-2,847 3.64 3.25-4.12 
South East Glasgow 1,650 1,489-1,847 2.29 2.06-2.56 
South West Glasgow 1,891 1,705-2,116 2.42 2.18-2.70 
West Glasgow 3,266 2,848-3,790 3.20 2.79-3.71 
5.2 Drug Injecting 
In this section we present estimates of the prevalence of drug injecting 
at the NHS Board and Council area level. Drug injecting was defined as 
the injecting of any drugs, not necessarily opiates or benzodiazepines 
(but not including the injecting of steroids). 
As noted in Chapter 3, a multiplier method was used in the Borders 
NHS Board area such that the proportion of opiate and / or 
benzodiazepines users who were estimated to be injecting in the 
Borders was set to be the same as the average across mainland 
Scotland. As also noted in Chapter 3 there were insufficient data to 
provide comparable estimates for the three Island NHS Board areas. 
The following tables provide the injecting prevalence estimate for 
mainland Scotland. Thus in total it has been estimated that there were 
23,933 drug injectors in Scotland in 2006. The highest prevalence rates 
are to be found in the Greater Glasgow & Clyde, Ayrshire & Arran and 
Grampian NHS Board areas. 
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Table 9 Estimates of the number of drug injectors by NHS 
Board area (mainland Scotland, age 15 to 64) 
Area Total Estimate Prevalence 
 N  95% CI %  95% CI
Ayrshire & Arran 2,373 1,716-3,461 0.99 0.72-1.45
Borders1 201   0.29
Dumfries & Galloway 486 371-669 0.52 0.40-0.71
Fife 1,270 1,077-1,527 0.53 0.45-0.64
Forth Valley 786 656-964 0.41 0.34-0.51
Grampian 3,056 2,457-3,887 0.85 0.69-1.09
Greater Glasgow & Clyde  8,862 7,091-11,330 1.10 0.88-1.40
Highland 734 458-1,325 0.37 0.23-0.66
Lanarkshire 1,649 1,122-2,606 0.44 0.30-0.70
Lothian  3,262 2,520-4,370 0.59 0.46-0.79
Tayside 1,254 1,016-1,592 0.49 0.40-0.63
MAINLAND SCOTLAND 23,933 21,655-27,143 0.71 0.64-0.80
1 Estimate for Borders NHS Board area was produced using a multiplier 
method (see Chapter 3) 
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Figure 12 Estimated prevalence of drug injecting by NHS Board 
area (mainland Scotland, age 15 to 64) 
 
 
 
Note: Estimate for Borders NHS Board area was produced using a multiplier 
method (see Chapter 3) 
 34
Figure 13 Estimated prevalence of drug injecting by NHS Board 
area (age 15 to 64) 
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Note: Estimate for Borders NHS Board area was produced using a multiplier 
method (see Chapter 3). This estimate does not have error bars attached to 
it, but is subject to error. 
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Table 10 presents the estimated number of drug injectors by Council 
area. 
From Table 10, the highest levels of injecting drug use are to be found 
in Inverclyde at 1.63% of the population aged 15 to 64, followed by 
Aberdeen City and Glasgow City with prevalence rates of 1.56% and 
1.35% respectively. 
Table 10 Estimates of the number of drug injectors by Council 
area (mainland Scotland, age 15 to 64) 
 
 
 
 
Area Estimate Prevalence 
 n  95% CI %  95% CI 
Aberdeen City 2,246 1,806-2,857 1.56 1.25-1.98 
Aberdeenshire 683 549-868 0.43 0.35-0.55 
Angus 217 176-275 0.31 0.25-0.39 
Argyll & Bute 286 179-517 0.49 0.31-0.88 
Clackmannanshire 215 180-264 0.66 0.55-0.81 
Dumfries & Galloway 486 371-669 0.52 0.40-0.71 
Dundee City 845 684-1,073 0.89 0.72-1.14 
East Ayrshire 998 722-1,456 1.27 0.92-1.85 
East Dunbartonshire 172 138-219 0.25 0.20-0.32 
East Lothian 108 84-145 0.18 0.14-0.24 
East Renfrewshire 185 148-236 0.32 0.26-0.41 
Edinburgh, City of 2,432 1,878-3,257 0.74 0.57-0.99 
Falkirk 417 348-512 0.42 0.35-0.51 
Fife 1,270 1,077-1,527 0.53 0.45-0.64 
Glasgow City 5,458 4,368-6,960 1.35 1.08-1.72 
Highland 448 279-808 0.32 0.13-0.57 
Inverclyde 874 700-1,115 1.63 1.30-2.07 
Midlothian 273 211-366 0.52 0.40-0.70 
Moray 127 102-162 0.22 0.18-0.29 
North Ayrshire 756 547-1,103 0.85 0.62-1.25 
North Lanarkshire 1,048 713-1657 0.48 0.33-0.76 
Perth & Kinross 193 156-244 0.21 0.17-0.27 
Renfrewshire 1,024 819-1,305 0.90 0.72-1.15 
Scottish Borders1 201   0.29  
South Ayrshire 618 447-902 0.86 0.62-1.26 
South Lanarkshire 1,056 773-1,529 0.52 0.38-0.75 
Stirling 153 128-188 0.26 0.22-0.32 
West Dunbartonshire 693 554-884 1.13 0.90-1.44 
West Lothian 449 347-602 0.40 0.31-0.53 
MAINLAND SCOTLAND 23,933 21,655-27,143 0.71 0.64-0.80 
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Figure 14 Estimated prevalence of drug injecting by Council 
  (non-rural area, age 15 to 64) 
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Figure 15 Estimated prevalence of drug injecting by Council 
  (rural area, age 15 to 64) 
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
1.60
1.80
2.00
Ab
erd
ee
ns
hir
e
An
gu
s
Ar
gy
ll &
 Bu
te
Du
mf
rie
s &
 G
all
ow
ay
Ea
st 
Ay
rsh
ire
Hig
hla
nd
Mo
ray
Pe
rth
 &
 K
inr
os
s
Sc
ott
ish
 B
ord
ers
So
uth
 A
yrs
hir
e
St
irli
ng
 
Note Estimate for Scottish NHS Board area was produced using a multiplier 
method (see Chapter 3). It is subject to error. 
 
5.3 Psychostimulants  
As noted in Chapter 4, data on psychostimulant use was obtained from 
all of the treatment, Police and Social Enquiry Report data sources 
across Scotland. It was not possible to ascertain the severity of an 
individual’s psychostimulant use (such as their cocaine use) or their 
level of dependency from the Police data source. For example, 
someone who only takes amphetamines in social settings such as a 
nightclub could not be differentiated from someone who is becoming 
dependent on the drug or injecting it. Therefore the psychostimulant 
users identified from the treatment data source could be substantially 
different from some of the psychostimulant users identified from the 
police data thus breaching one of the assumptions of the capture-
recapture methodology. Assuming that all contributing data sources 
encompassed similar cohorts of psychostimulant users, i.e. they did not 
include infrequent or recreational users along with heavy users or those 
experiencing problems due to addiction to those drugs, various 
capture-recapture analyses could be undertaken. These have been 
done and the results are available on request. It should be noted, 
however, that although estimates have been produced it is unclear as 
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to what they actually refer to, i.e. ever use of cocaine in 2006, regular 
use, problematic use etc. 
In contrast to the 2003 study it was not possible to derive any estimates 
of the prevalence of crack cocaine use, not even in Aberdeen City 
where there were large enough numbers of people identified by 
treatment data sources or Social Enquiry reports. Unfortunately it is not 
possible to identify crack cocaine use from Hospital data and the data 
supplied by Scotland’s Police forces included very few identifiable 
cases of crack cocaine possession, not least because some forces did 
not differentiate between cocaine powder and crack cocaine offences.   
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6 Comparison between 2003 and 2006 estimates 
In this section brief comparisons are drawn between the results of the 
2006 study and the previous study that presented estimates for 2003. 
Table 11 presents a comparison between the prevalence rates 
estimated in the 2003 study and those estimate in the 2006 study by 
council area. In contrast to the earlier sections in this report, the 2006 
estimates have been converted to rates using the populations aged 15 
to 54 as the baseline. As previously noted, there were minimal 
numbers of people identified in the 55 to 64 age category 
(approximately half of 1% of cases). This would have virtually no 
impact on the estimated numbers therefore we contend that this table 
presents like for like comparisons.  
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Table 11  Comparison between the 2003 and 2006 problem 
drug use prevalence estimates by Council area (age 
15 to 54) 
 
 
Area 2003 2006 
 %  95% CI %  95% CI 
Aberdeen City  2.03 1.87-2.27 2.14 1.93-2.39 
Aberdeenshire 1.10 0.95-1.42 1.00 0.91-1.12 
Angus 1.99 1.50-3.53 1.59 1.35-1.91 
Argyll & Bute 1.35 1.09-2.16 1.22 0.94-1.64 
Clackmannanshire 1.05 0.88-1.53 1.93 1.50-2.59 
Dumfries & Galloway 2.43 2.15-2.94 2.03 1.71-2.46 
Dundee City 2.80 2.51-3.22 3.13 2.81-3.75 
East Ayrshire 1.92 1.73-2.22 2.90 2.66-3.22 
East Dunbartonshire 0.69 0.51-1.50 0.84 0.60-1.23 
East Lothian 1.74 1.40-2.86 1.89 1.56-2.35 
East Renfrewshire  1.40 1.09-3.67 1.17 0.89-1.60 
Edinburgh, City of 2.10 1.92-2.37 1.88 1.75-2.04 
Falkirk 1.08 0.94-1.34 1.09 0.96-1.25 
Fife 1.60 1.43-1.97 1.57 1.47-1.70 
Glasgow City 3.31 3.16-3.49 3.77 3.63-3.97 
Highland 0.81 0.63-1.46 0.93 0.72-1.44 
Inverclyde 2.57 2.35-2.91 3.18 2.69-3.94 
Midlothian 1.46 1.25-2.22 1.55 1.38-1.78 
Moray 0.66 0.39-3.48 0.66 0.56-0.81 
North Ayrshire 1.85 1.69-2.11 2.57 2.35-2.89 
North Lanarkshire 1.06 0.96-1.22 1.80 1.62-2.05 
Perth & Kinross 1.76 1.44-2.44 1.24 1.05-1.56 
Renfrewshire 2.41 2.05-3.01 2.25 2.01-2.55 
Scottish Borders 1.25 0.95-2.38 0.85 0.69-1.09 
South Ayrshire 1.88 1.55-2.61 1.88 1.69-2.11 
South Lanarkshire 1.72 1.40-2.77 1.80 1.62-2.01 
Stirling 1.49 1.05-3.62 1.61 1.28-2.06 
West Dunbartonshire 2.22 1.81-2.46 3.18 2.84-3.60 
West Lothian 1.11 1.00-1.34 1.10 1.00-1.21 
SCOTLAND1 1.84 1.84-2.01 1.98 1.95-2.05 
1  The Scotland rate includes the Island Council areas. 
 
From Table 11 the national prevalence has increased from 1.84% in 
2003 to 1.98% in 2006. However, there have been changes in 
methodology between 2003 and 2006, including the use of hard 
matching to replace soft matching and the extension of the age range 
to include 55-64 year olds, both of which will tend to inflate the estimate 
for 2006 compared to that for 2003. Thus it is not possible to carry out 
a formal test of statistical significance between years. 
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When looking at the changes in prevalence at the local level, there are 
five Council areas where the prevalence has increased to the extent 
that the confidence interval for the 2006 estimate does not overlap with 
the confidence interval for the 2003 (thus being indicative of a 
statistically significant increase). It should, however, be noted that 
when making multiple comparisons at the 95% level of significance, it 
would be expected that around 5% of comparisons would appear to be 
significant even when there has not been a true increase or decrease 
in prevalence.  
There appears to have been statistically significant increases in 
prevalence in East Ayrshire and North Ayrshire, with the prevalence in 
East Ayrshire rising from 1.92% (95% CI 1.73-2.22%) to 2.90% (95% 
CI 2.66-3.22%) and the prevalence in North Ayrshire rising from 1.85% 
(95% CI 1.69-2.11%) to 2.57% (2.35-2.89%). As these Council areas 
are neighbouring each other (and within the same NHS Board area) the 
increase could be due to an underlying increasing trend in the 
prevalence of problem drug use in that part of Scotland. Alternatively it 
could be due to an issue with the data from NHS Ayrshire and Arran (or 
other data collated at the NHS area level within that area) either in 
2003 or 2006. Interestingly the prevalence rate in South Ayrshire 
remained exactly the same at 1.88%. 
There also appears to have been a statistically significant increase in 
the North Lanarkshire Council area. The prevalence in 2003 was 
1.06% (95% CI  0.96-1.22%); a prevalence rate that appeared low 
compared to neighbouring Council areas that year. The prevalence rate 
in 2006 is 1.80% (95% CI 1.62-2.05%). 
The prevalence rate in West Dumbartonshire also seems to have 
significantly increased, from 2.2% (95% CI 1.81-2.46%) to 3.18 (95% 
CI 2.84-3.60%). West Dumbartonshire therefore continues to be one of 
the Council areas with the highest prevalence in Scotland. Finally 
Glasgow, the largest Council area, with the highest prevalence rate, 
has seen a statistically significant increase between 2003 and 2006, 
with the prevalence increasing from 3.31% (95 CI 3.16-3.49%) to 
3.77% (95% CI 3.63-3.97%). It is, however, worth noting that the actual 
increase is relatively small compared to other Council areas, but the 
size of the Council area means that it is often easier to find significant 
changes in Glasgow compared to the areas with smaller population 
bases.  
In terms of drug injecting the prevalence increased from 18,737 in 2003 
to 23,933 in 2006. The increase in like for like rates (age 15 to 54) is 
from 0.67% (95% CI 0.63-0.72%) to 0.86% (95% CI 0.77-0.97%). 
There have, however, been some data quality issues and resultant 
methodological changes that would suggest it may not be appropriate 
to regard this as true increase in the prevalence of drug injecting in 
Scotland between 2003 and 2006.  
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7 Discussion and Conclusions 
 
This report provided estimates of the prevalence of opiate and / or 
benzodiazepine use at the Council, ADAT, NHS Board, Community 
Justice Authority and Police Force level. These estimates have been 
combined to provide a national estimate of the number of people in 
Scotland in 2006 who use drugs such as heroin, other opiates 
(including methadone) or illicitly use benzodiazepines. The estimates 
can be directly compared with previous estimates for 2000 and 2003 
(and to a certain extent other areas within the United Kingdom and 
Europe). There appears to be a small rise in the number of people 
estimated to be opiate and / or benzodiazepine users, however the 
figures in this report are estimates and therefore have to be considered 
along with their associated confidence intervals. The confidence 
intervals have quite a large degree of overlap but changes in 
methodology between 2000 and 2006 preclude a formal test of 
significance.  However, it is probably appropriate to conclude that, over 
the time period 2000 to 2006 the level of opiate and / or 
benzodiazepine use in Scotland has remained stable, and at a level 
that is significantly higher than in other parts of the UK. The reasons 
why opiate and / or benzodiazepine use in Scotland is higher than 
England are beyond the scope of this study, but we would contend that 
it is unlikely to be due to the differences in case definitions between the 
Scotland and England estimates. Compared to previous Scottish 
studies, this study has been more rigorous in identifying opiate use 
separately from opiate and / or benzodiazepine use. Less than half of 
1% of those identified from treatment were using benzodiazepines 
without also using opiates, similarly less that 1% of the Social Enquiry 
Report sample referred to people using benzodiazepines only. Thus it 
is highly unlikely that the estimate of 55,328 includes significant 
numbers of benzodiazepines only users.  
Methodological Issues 
 
We have collated information from four distinct sources of data on 
opiate and / or benzodiazepine use in Scotland. Each of these data 
sources has a national coverage; however many of the sources are 
primary local databases that are collated at the national level, either 
specifically as part of this study or by national organisations.  
 
The Scottish Drug Misuse Database and the SMR01 data (hospital 
discharges) are national databases collated by the NHS in Scotland. As 
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each rely on local data providers supplying information to the national 
database, it is possible that there are regional or local variations in the 
quality or completeness of the databases. Comparability should not be 
too much of an issue for the SMR01 data, but the Scottish Drug Misuse 
Database collates information from a wide range of treatment and 
support agencies across Scotland and therefore the possibility of local 
variations in reporting practices is greater in that database. Regardless 
of data quality or completeness, as the Scottish Drug Misuse Database 
records new contacts at treatment or support services, the chance that 
an individual drug user appears in the database could depend on local 
issues, such as retention rates within services, varying service 
provision and varying rates of incidence (as opposed to prevalence 
rates). More generally, the nature and extent of treatment / service 
provision (including length of waiting lists) may mean that some drug 
users are more likely to appear in treatment data than others. 
 
The Social Enquiry Report data were collected by the study team. 
Access was negotiated to all Social Enquiry Reports completed within 
the relevant time period, however it is possible that reports were 
missing or that the data collectors overlooked files containing valid 
Social Enquiry Reports. Moreover there may be regional or local 
differences in the way that Social Enquiry Reports are completed, such 
that some areas may be more rigorous in recording drug use. This 
issue, coupled with the issue that there may be local differences in the 
propensity for a drug user to commit crime (and also that such crimes 
are detected) will again possibly make some drug users more likely to 
appear in the Social Enquiry Report data than others. Local variations 
in crime rates and the policing response may also mean that there are 
local variations in the chance that a drug user appears in the Police 
data due to Misuse of Drugs Act crimes.  
 
These issues may combine to mean that capture-recapture 
propensities may differ across areas. This should not be a problem for 
the analysis if the variation is at the Council area level (or higher area 
level) as the best log-linear model is fitted to the data at the Council 
area level. Thus the model fitted to the data in, for example, Aberdeen 
City may be completely different to the model fitted in Aberdeenshire. 
The strategy used within the analyses was to fit the simplest 22 models 
to the available data (including to the data stratified by age group and / 
or gender) and this approach was sufficient to allow good-fitting models 
to be fitted in each area apart from Orkney (where there were too few 
data).  
 
Over and above the issue that data sources could vary across Scotland 
due to them being primarily local data sources collated up to the 
national level, there did appear to be issues with certain data sources 
in certain areas. We have to stress that this is in no way a criticism of 
the contributing data sources. If there are data quality issues, they 
could have occurred at any point in the data collection or analysis 
process, therefore it does not automatically mean that if we had 
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difficulty using the data in the analyses, then there is a problem with the 
organisation or agency that supplied it. The capture-recapture method 
only works when it is possible to fit a statistical model to the overlap 
data. If there are problems with an individual data source, then usually 
it is not possible to fit a model to the data. For example if the initials in a 
data source were switched, with forename initial switching with 
surname initial in one data source, it usually becomes immediately 
apparent that something is wrong somewhere in the analysis.  Another 
feature of the capture-recapture method is that the size of the 
contributing data sources should not adversely affect the size of the 
estimates. Thus increasing treatment coverage should not 
automatically mean higher prevalence estimates. An increase in the 
size of a contributing data source should only increase the accuracy of 
the estimate, for example by decreasing the width of the associated 
95% confidence interval, unless there are problems with the data 
source such as data quality issues or inclusion of individuals who do 
not meet the case definition. In most council areas, the inclusion of 
data collected directly from treatment agencies did not substantially 
alter the estimate prevalence rate for that area, apart from in three 
areas where not only did the estimate substantially change, but there 
was a significant deterioration in how well the statistical models fit the 
overlap data. This could be for a number of reasons, many of which 
could be due to data quality issues in contributing agency or problems 
occurring within the analysis. Where such problems have occurred (in 
Aberdeen City, Highland and Stirling) we have omitted the data 
collected directly from the treatment services. As this would not 
significantly have decreased or increased the prevalence rates had we 
done this in the remaining areas in Scotland, it is perhaps safe to 
assume that the estimates derived without the directly collected 
treatment service data are reliable.  
 
In contrast to the 2003 analyses, this study used hard matching to 
identify overlaps between data sources. It is to be expected that, by 
switching from soft matching to hard matching, the number of 
individuals identified in more than one source would decrease. In a 
two-sample capture-recapture analysis this reduction in the overlap 
cases would automatically result in an increase in the estimate. 
Although it does not always follow that this would happen in a four-
sample capture-recapture analysis (as model selection will have an 
impact on the estimates), previous unpublished reports for the Home 
Office suggest that hard matching does tend to increase the estimates, 
although not at a level that would statistically significantly increase 
them.  
 
We have increased the upper limit of the age range to 64. Less than 
half of one percent of the ‘known’ population were in the 55 to 64 age 
range. It would be beyond the scope of this project to re-run all the 
analyses again excluding the 55 to 64 year olds, but it is likely that 
increasing the age range to 64 would have a very minimal effect on the 
estimated number of problem drug users. It could, however, have the 
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effect of decreasing the prevalence rate as the denominator population 
would have increased. We have therefore made comparisons using the 
same baseline populations.  
 
Data issues 
The study has also provided estimates of the prevalence of drug 
injecting at the Council and NHS Board area levels. It has to be stated 
that there were difficulties in obtaining injecting estimates. It is difficult 
to gauge how these issues would affect the estimates. The available 
data on injecting drug use is sparse. As noted in the relevant chapter, 
there are issues about assuming that hepatitis C test data refer to 
current injectors. Over and above that issue there may be issues with 
the reliability of the identifier information contained in blood-borne virus 
databases. It has to be clearly stressed that this should not be seen as 
a criticism of such databases or the clinicians completing the forms. It 
is more that such databases were not specifically set up for the 
purpose of contributing to a capture-recapture study and problems with 
missing identifiers or possible confusion about the ordering of initials 
would be a fairly minor issue for a surveillance system. Such issues if 
they were present would, however, be fairly problematic for this type of 
prevalence estimation study. Thus although the increase in the 
prevalence of injecting does appear to be statistically significant, we 
contend that methodological differences coupled with potential data 
quality issues would make such a reliance on a statistical measure of 
significance wrong.  We would suggest that, just with opiate and / or 
benzodiazepine use, the prevalence of drug injecting appears to be 
stable over the six year period 2000 to 2006. 
This study has been particularly difficult to carry out, far harder than in 
similar studies (with same research design carried out by the same 
study team) in 2000 or 2003. There were substantial problems in 
getting access to Social Enquiry Reports in at least one Council area. 
Eventually the data protection issues were resolved, but it took a 
substantial time to sort them out. Also in the 2006 study, there was a 
substantial delay in getting approval from NHS Board’s Research & 
Development departments (which was a stipulation of the Research 
Ethics agreement).  
More importantly, and perhaps more worryingly, the quality of data that 
the study team could access from drug treatment services was often 
patchy. Again, this should not be seen as a criticism of drug treatment 
services; the data requirements of a capture-recapture study are quite 
specific such that whilst an information system within a treatment 
service may be good at providing staff with the required information for 
the successful running of their service it might at the same time be 
actually be pretty poor at providing relevant data for capture-recapture 
studies. The study encountered various different systems across 
Scotland. Some agencies could provide identifier information on their 
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clients (such as initials, dates of birth) but did not routinely collate 
information on the drugs someone used in an easily accessible format. 
This resulted in the study team having to make data requests to other 
parts of the NHS to access the data and piece together the information 
in order to construct a viable data source. In some areas the only 
option was to cross-reference the data from treatment agencies with 
the information collated within the Scottish Drug Misuse Database. As 
this database has been up and running for over 10 years and should 
record information on every new contact at a drug treatment service, it 
would be thought unlikely that drug users in contact with services in 
2006 would never appear in the national database. However the 
attempts at cross-referencing treatment data collated from agencies 
with the Scottish Drug Misuse Database was not completely 
successful. It is beyond the scope of this study to identify why. 
Moreover, it was interesting to note that some of the areas where we 
had to resort to cross-referencing with the Drug Misuse Database were 
the ones where it was not possible to fit models to the resultant overlap 
data. This could be because such cross-referencing between the 
databases somehow violated one of the assumptions of the capture-
recapture method, such that only those for whom we can link with the 
Scottish Drug Misuse Database have any chance of appearing in the 
treatment data. There may be (possibly unknown) reasons why we 
cannot cross-reference some individuals, and thus there could be a 
group of drug users that have no chance of appearing in the analysis, 
thus contributing to a violation of the equal catchability assumption. 
Conclusions 
It is lamentable that, given the significant harm caused to individuals 
and society because of drug use and the clearly higher levels of opiate 
use in Scotland, the ‘drugs information infrastructure’ has not 
developed in this part of the UK as well as in England. Our judgement 
is informed by our experience of carrying similar exercises for the 
Home Office, where all relevant data is held centrally and relatively 
readily available.  In England, all Police data and Probation data (the 
equivalent of Scotland’s Social Enquiry Report Data) are all held 
centrally by the Ministry of Justice and subject to appropriate data 
security, ethical and confidentiality controls, available for inclusion in 
prevalence estimation studies. The Drugs Intervention Programme in 
England also provides two national databases on drug misuse: drug 
users in prison and drug users receiving criminal justice interventions in 
the community.  
However the most concerning problem with the drugs information 
infrastructure in Scotland is the fact that nobody has a clear idea of the 
number of drug users in contact with treatment services. Within 
England this information is readily available from the National Drug 
Treatment Monitoring System, to the extent that Drug Action Teams in 
England can access reports on a monthly basis charting the numbers 
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of clients in treatment (not just new clients or numbers on the waiting 
lists). Within the context of the research which this report is based upon 
we have had to piece together the equivalent information for Scotland. 
On that basis we would suggest that the 22,474 individuals identified as 
being in treatment in 2006 should only be seen as a minimum number 
of individuals in treatment.  
These data quality issues have partly been resolved by adjusting the 
methodology (such as excluding data collected directly from treatment 
agencies when they clearly cause the models not to fit to the overlap 
pattern). Various sensitivity analyses carried out but not summarised in 
this report appear to demonstrate that such methodological 
adjustments do not seem to adversely impact on the prevalence rates, 
but that assertion cannot be tested. For opiate and / benzodiazepine 
use we are confident that the estimates are valid and comparisons 
between the 2006 estimates and previous ones are appropriate. 
However the data quality issues, coupled with the relatively sparse 
number of injectors identified from the contributing data sources, lead 
us to recommend that the available injecting estimates (for 2000, 2003 
and 2006) should be considered with caution and care should be taken 
in ascribing any trend information. 
Finally, it does have to be clearly recommended that a lot of the 
problems with carrying out a prevalence estimation study in Scotland 
would be eliminated if such a programme of research was funded on a 
yearly ‘rolling’ basis. Our experience in carrying out three Scottish 
studies on a staccato basis every three years is that every time the 
research is initiated to produce prevalence estimates the research 
team effectively have to start from scratch in negotiating access to the 
relevant data in resolving data quality issues and in negotiating the 
increasing complexity that is the world of ethical approval in research.  
Each iteration in the prevalence estimation research in Scotland has 
also involved a heavy workload in securing the necessary NHS 
research and development approval coupled with the need to 
familiarise data providers and other colleagues about the methods of 
prevalence calculation and data capture. This is in stark contrast to the 
programme of research that was carried out in England across all 149 
Drug Action Team areas (funded by the Home Office and undertaken 
by the same research team that has completed the present and 
previous problem drug misuse prevalence studies in Scotland) where 
large numbers of policy relevant estimates, including different case 
definitions, could be generated relatively easily and more importantly 
regularly through the period of that three year study.  
Notwithstanding the above methodological cautions, the study has 
provided policy-relevant estimates of the number of opiate and / or 
benzodiazepine users in Scotland that can be directly compared with 
previous years, across the different areas within Scotland and against 
other areas of the UK. The estimates we have produced appear to be 
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stable and at a rate far higher than in England. This is not something 
that we can afford to be at all complacent about in Scotland.  
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Table A1  Estimated population sizes and composition of NHS Board areas in terms of Council  areas and postcode 
districts used to assign area 
 
NHS Board area Council Area Estimated population (15-64) Total Postcode districts used to assign to area 
Ayrshire & Arran East Ayrshire 78,900   KA1-KA5, KA16-KA18 
  North Ayrshire 88,500   KA11-KA15, KA20-KA25, KA26-KA30, PA17 
  South Ayrshire 71,800   KA6-KA10, KA19, KA26 
  Total   239,000   
Borders Scottish Borders 70,500 70,500 EH38, EH43-EH46, TD1-TD14 
Dumfries & Galloway Dumfries & Galloway 93,700 93,700 DG1-DG15, DG16 
Fife Fife 238,200 238,200 DD6, KY1-KY12, KY14-KY16 
Forth Valley Clackmannanshire 32,700   FK10-FK14 
  Falkirk 99,900   EH51, FK1-FK6 
  Stirling 58,000   FK7-FK9, FK15-FK21, G63 
  Total   190,400   
Grampian Aberdeen City 144,200   AB10-AB16, AB21-25 
  Aberdeenshire 156,900   AB30-AB36, AB39, AB41-AB45, A51-AB54 
  Moray 56,600   AB37, AB38, AB55, AB56, IV30-IV32, IV36 
  Total   357,900   
Greater Glasgow & 
Clyde East Dunbartonshire 68,400   G61, G63, G64, G66 
  East Renfrewshire 57,300   G46, G76-G78 
  Glasgow City 405,500   G1-G5, G11-G15, G20-G23, G31-G34, G40-G45, G51-G53, G69 
  Inverclyde 53,800   PA13-PA16, PA18, PA19 
  Renfrewshire 113,400   PA1-PA12 
  West Dunbartonshire 61,300   G60, G81-G83 
  South Lanarkshire (part) 49,400   G72, G73 
  Total   809,100   
Highland Argyll & Bute 58,600   G84, PA20-PA38, PA41-PA49, PA60-PA78 
  Highland 140,700   IV1-IV28, IV40-IV49, IV51-IV56, IV63, KW1 - KW3, KW5-KW9, PH19-PH26, PH30-PH44, PH49, PH50 
  Total   199,400   
Lanarkshire North Lanarkshire 217,300   G65, G67, G68, G71, ML1, ML2, ML4-ML7  
  South Lanarkshire (part) 155,900   G74, G75, ML3, ML8-ML12 
  Total   373,200   
Lothian East Lothian 59,200   EH21, EH31-EH36, EH39-EH42 
  Edinburgh, City of 329,500   EH1-EH17, EH28-EH30 
  Midlothian 52,100   EH18-EH20, EH22-EH26, EH37 
  West Lothian 112,800   EH27, EH47-EH49, EH52-EH55 
  Total   553,500   
Orkney Isles Orkney Isles 12,900 12,900 KW15-KW17 
Shetland Isles Shetland Isles 14,400 14,400 ZE1-ZE3 
Tayside Angus 70,000   DD7-DD11, PH12 
  Dundee City 94,500   DD1-DD5 
  Perth & Kinross 90,000   KY13, PH1-PH11, PH13-PH18 
  Total   254,500   
Western Isles Eilean Siar 16,800 16,800 HS1-HS9 
SCOTLAND TOTAL   3,423,500   
 
Notes 
The population sizes (aged 15 to 64 years of age) for Council areas and NHS Board areas are taken from the mid-year estimates 
for 20061. For CHP areas (not presented), the proportion of the population (aged 16 to 64 years of age in mid 2006)2 of the relevant 
NHS Board areas that live in the constituent CHP areas was applied to the NHS Board totals. 
 
In general the postcode districts (e.g. EH7) listed in Tables A1 to A4 were used to indicate the area of residence of individual found 
within the contributing data sources. However there were some cases in the postcode sector (e.g. EH7 6), when available, was 
used to allocate area of residence, particularly if the postcode district straddled more than one area. In the absence of postcode 
district or postcode sector information, other relevant geographical information (such as town of residence) was used where 
appropriate. The mapping from postcode information to area of residence is based on information the proportion of live postal 
addresses in each postcode district / sector residing the Council / NHS Board area. For example, all of the postal addresses in the 
EH7 postcode district refer to City of Edinburgh address there all drug users identified with a EH7 postcode district will be assigned 
to the City of Edinburgh. For the EH49 postcode district, 91% of the postal addresses refer to a West Lothian address and thus all 
drug users with a EH49 postcode district would be allocated to West Lothian  
 
All population estimates have been rounded to the nearest 100. Columns may not add up due to this rounding. 
                                            
1 http://www.statistics.gov.uk/statbase/Product.asp?vlnk=15106 
2 http://www.scotpho.org.uk/profiles/ 
 
